Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database".

Cite this paper

@article{Singh2016BoneMP, title={Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database".}, author={Kern Singh and Dustin H. Massel and Benjamin C Mayo and Daniel Bohl and William W Long and Krishna D Modi}, journal={The Journal of bone and joint surgery. American volume}, year={2016}, volume={98 13}, pages={e57} }